JENNIFER VERMAAK: Open Payments
NPI 1700118882 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 17 payments from 8 companies in 2025. Trend: 2023 $756 · 2024 $16 · 2025 $434
Food & beverage: $334Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $121 |
| ABBVIE INC. | 4 | $96 |
| UCB, Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: TREMFYA, Bimzelx, SKYRIZI, TALTZ, RINVOQ, INGREZZA, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across MS — which companies pay providers there.
